The move disappoints many who thought global uncertainty would prompt the bank to act.
Dollar gains 2.4 percent in four days, euro 2.8 percent.
TA-25 to become TA-35; TA-100 expanded to TA-125 as benchmarks will widen in bid to up trading volumes.
888’s bid for Bwin upstaged by GVC; Bank of Israel holds base rate unchanged; Tel Aviv shares are mixed as Teva rallies amid China jitters
Teva seeks medical-marijuana patents; FIMI raising $1 billion for private equity fund; Tiv Taam makes offer to Eden Teva Market.
Key executive quits ailing Mega supermarkets;Elbit wins $150m contract from Dutch; Playtech buys Israel’s Ava Trade for $105 million.
Benchmark index ends 1.8% lower; energy stocks hit by delays in decision on gas cartel.
Knesset Finance Committee seeking to delay steps toward sale of Israel Military Industries; TASE down amid global concerns about Greece, but bank shares rise; Alcobra drug fails mid-stage trial, sending its shares tumbling in New York.
12.2% of TASE companies have ‘going concern’ warnings; Hamat in talks to build Turkish plant; PhotoMedex sells unit to repay banks.
$14-a-share price is 16% premium over company's Nasdaq price on the eve of the announcement.
Analysts believe Tel Aviv stocks will rebound quickly if Greeks exit the euro and declare bankruptcy.
Delek in talks to boost stake in Cyprus gas field, Azrieli in pact to sell Supergas to Tadiran, and telecoms stocks carry TASE higher.
Plus500 unfreezes most customer accounts after review; Emerson to buy Spectronix for $79 million; Tel Aviv shares rise as Greek crisis fades.
Nice reports 26% rise in first-quarter profit; Nitzba wins TA bus station bidding; Ormat wins contract day after drop in profit; Kornit shares climb after strong earnings; Bank stocks lead TA-25 index higher.
Kornit jumps 40% on first day of trading, Teva to pay $24m in pay-for-delay suit and shares edge up in short trading day.
New York developer Extell raises 600 milion shekels; Bino hands over shares to children; TA-25 closes at record high before Pesach.
Teva announces success in test of new drug chronic migraine drug; Allot Communications to acquire operations of Madrid-based Optenet; TASE retreats from record high, energy stocks slide over antitrust decision.
Unilever joins state tech program, My Size looks to expand, while Uber gets free ride on Channel 10 election show.
LivePerson profit falls despite jump in sales, Israel Corporation severs last ties with Qoros.
Alon rejects ex-CEO's offer to acquire its retail group; Wix narrows 4Q loss, sees profit in 2015l Stocks perform better after elections than before, study finds.
Thirty stocks account for 75% of TASE trade; Allot reports rise in net as sales climb 12%; RedHill raises $12.5m in offering of ADSs; TA-25 up on talk of Greek debt compromise.
Markstone withholds part of bond repayment, Radcom revenues rally, TASE follows Wall Street up.
Piper Jaffrey has been selected to manage the sale of the company.
Last year was less than brilliant for U.S.-listed Israeli biomedical firms, but if you’re willing to take on risk here are a half-dozen that are developing treatments for everything from acne and burns to Parkinson’s disease.
Qoros' car sales jumped in fourth quarter; Moody's cuts Discount's deposit rating; Somoto tumbles on Apple clarifications.
Both foreign currencies lose more than 1% of their value.
Decline would have been steeper except for higher housing costs.
America's ‘Dr. Cannabis,’ Alan Shackelford, says Israel's openness and its 50-year history of marijuana research puts it in the vanguard of the medical-marijuana field.
Migdal moving forward with giant placement, UBS cuts target prices for gas shares but says most are Buys.
Hadera Paper mulls closing Turkish venture; Psagot warns on stocks facing regulation; Jordan suspends gas talks with Israel; TA-25 shares follow Wall Street lower.